Rochester Medical Corporation engages in the development, manufacture, and marketing of PVC-free and latex-free urinary continence and urine drainage care products for the home and acute care markets. Its home care products include a line of silicone and latex male external catheters for managing male urinary incontinence; intermittent catheters for managing both male and female urinary retention, including Magic 3 line of silicone intermittent catheters; and the FemSoft Insert, a soft, liquid-filled, urethral insert for managing stress urinary incontinence in adult females. The company manufactures male external catheters in six models, including UltraFlex, Pop-On, Wide Band, Natural, Clear Advantage, and Transfix catheters; and intermittent catheters in four versions that include standard, antibacterial, hydrophilic, and antibacterial personal catheters. Its acute care products include a line of standard Foley catheters and Strata brand of Foley catheters; and Strata-NF Catheter, an antibacterial Foley catheter that reduces the incidence of hospital acquired urinary tract infection. The company’s primary customers include distributors, extended care facilities, and individual hospitals and healthcare institutions. It markets its products under the Rochester Medical brand name through a direct sales force in the United States, the United Kingdom, and the Netherlands, as well as through independent distributors in other international markets. The company also supplies its products to various medical product companies for sale under private label brands owned by these companies. Rochester Medical Corporation was founded in 1988 and is headquartered in Stewartville, Minnesota.

Key Statistics